Beliefs, Attitudes, and Response to Genetic Testing in SarcomaPatients
ConditionLeiomyosarcoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Utah
About this trial
Genomic research has shown that a portion of leiomyosarcomas can be attributed to an underlying cancer predisposition syndrome. However, the optimal approach for incorporating germline testing into the care of these patients. This study is assessing the beliefs about the heritability of leiomyosarcoma and other cancer risks, and attitudes towards germline testing among leiomyosarcoma patients.
Eligibility criteria
Qualifiers
Actionable germline PV detected in the research context
Living
No prior germline testing for this PV
Able to speak and read English
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
300 Participants
are grouped into 2 trial groupsSponsors and collaborators
University of Utah
Lead sponsor
National Cancer Institute (NCI)
Collaborator
University of New South Wales
Collaborator
University of Michigan
Collaborator
Source ClinicalTrials.gov